Polyarteritis nodosa complicated by antiphospholipid syndrome

Southern Medical Journal

Volumn 101, Issue 4, 2008, Pages 419-421

  Musuruana, Jorge L ^a   Cavallasca, Javier A ^a  

^a Hospital JBIturraspe Santa Fe   (Argentina)

Author keywords

Anticardiolipin antibodies; Antiphospholipid syndrome; Polyarteritis nodosa; Systemic vasculitis

Indexed keywords

ACENOCOUMAROL; CARDIOLIPIN ANTIBODY; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PREDNISONE;

ABDOMINAL PAIN; ADULT; ANTIBODY TITER; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTHRALGIA; ARTICLE; CASE REPORT; DIGITAL SUBTRACTION ANGIOGRAPHY; EOSINOPHIL; HEMATOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOVOLEMIC SHOCK; IMMUNOSUPPRESSIVE TREATMENT; INTERMITTENT CLAUDICATION; INTERNATIONAL NORMALIZED RATIO; LEG AMPUTATION; MALE; MYALGIA; PARESTHESIA; PERIPHERAL ISCHEMIA; POLYARTERITIS NODOSA; THROMBOSIS; TISSUE NECROSIS; TREATMENT DURATION; TREATMENT RESPONSE; VASCULITIS;

ADULT; ANTIPHOSPHOLIPID SYNDROME; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; HUMANS; MALE; POLYARTERITIS NODOSA;

EID: 41949130633     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318167d963     Document Type: Article

References (15)

1. Colmegna I, Maldonado-Cocco JA. Polyarteritis nodosa revisited. Curr Rheumatol Rep 2005;7:288-296.
2. . Bertolaccini ML, Khamashta MA, Hughes GR. Diagnosis of antiphospholipid syndrome. Nat Clin Pract Rheumatol 2005;1:40-46..
3. Hansen KE, Moore KD, Ortel TL, et al. Antiphospholipid antibodies in patients with Wegener's granulomatosis and polyarteritis nodosa. Arthritis Rheum 1999;42:2250-2252.
4. Rees JD, Lanca S, Marques PV, et al. Prevalence of the antiphospholipid syndrome in primary systemic vasculitis. Ann Rheum Dis 2006;65:109-111.
5. Egan AC, Caleyachetty R, Sabharwal T, et al. Endocarditis and ulnar artery aneurysm as presenting features of antiphospholipid syndrome and polyarteritis nodosa. Lupus 2005;14:914-917.
6. Valeyrie L, Bachot L, Roujeau JA, et al. Neurological manifestations of polyarteritis nodosa associated with the antiphospholipid syndrome. Ann Med Interne (Paris) 2003;154:479-482.
7. Norden DK, Ostrov BE, Shafritz AB, et al. Vasculitis associated with antiphospholipid syndrome. Semin Arthritis Rheum 1995;24:273-281.
8. Morelli S, Perrone C, Paroli M. Recurrent cerebral infarctions in polyarteritis nodosa with circulating antiphospholipid antibodies and mitral valve disease. Lupus 1998;7:51-52.
9. Dasgupta B, Almond MK, Tanqueray A. Polyarteritis nodosa and the antiphospholipid syndrome. Br J Rheumatol 1997;36:1210-1212.
10. Guillevin L, Pagnoux C. When should immunosuppressants be prescribed to treat systemic vasculitides? Intern Med 2003;42:313-317.
11. Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-997.
12. Khamashta MA, Hunt BJ. Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No. J Thromb Haemost 2005;3:844-845.
13. Crowther MA, Ginsberg JS, Julian J, et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 2003;349:1133-1138.
14. Finazzi G, Marchioli R, Brancaccio V, et al. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost 2005;3:848-853.
15. Han BK, Inaganti K, Fahmi S, et al. Polyarteritis Nodosa Complicated by Catastrophic Antiphospholipid Syndrome. J Clin Rheumatol 2004;10:210-213.